The integration of probiotics and prebiotics into mainstream health products highlights the importance of regulatory, safety, and market trends. Regulatory frameworks ensure that these products meet quality and safety standards, safeguarding consumer health while promoting trust in the industry. A comprehensive understanding of safety measures, including toxicity studies and clinical evaluations, is vital for developing products that deliver promised benefits without risks. Market trends shape the industry’s future, with a surge in demand for natural and functional foods driving innovation and competition. The convergence of regulatory guidelines, safety protocols, and evolving market preferences creates opportunities for businesses to align their strategies with consumer expectations. Discussions on these trends not only address compliance challenges but also explore strategies for market expansion and product diversification.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India